Clinical Trial Update: Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GM-CSF for patients with rising PSA in prostate cancer; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) (sargramostim)

Snippet

Sponsor: University of California, San Francisco | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED